Skip to Main Content

Advertisement

Skip Nav Destination

Issues

TOP READS

J Immunol (2022) 208 (10): 2257.

BRIEF REVIEWS

J Immunol (2022) 208 (10): 2259–2266.

CUTTING EDGE

J Immunol (2022) 208 (10): 2267–2271.

  • Spike-specific B cells are maintained following recovery from SARS-CoV-2 infection.

  • Tonsil germinal center spike-specific B cells are present after SARS-CoV-2 infection.

  • Tonsil B and Tfh cell responses could play a role in durable SARS-CoV-2 immunity.

ANTIGEN RECOGNITION AND RESPONSES

J Immunol (2022) 208 (10): 2273–2282.

  • NEDD8 fusion to a model protein results in proteasome and autophagosome degradation.

  • NEDD8 fusion is less efficient than ubiquitin fusion for peptide presentation.

  • DRiP Ag presentation is diminished by MLN4924 treatment.

CLINICAL AND HUMAN IMMUNOLOGY

J Immunol (2022) 208 (10): 2283–2299.

  • Early-stage alterations were evident in peripheral sTREM2-related inflammatory activity.

  • These alterations implicate early inflammatory cell development and recruitment signaling in AD.

  • Patterns of inflammatory activity are altered across all AD stages.

J Immunol (2022) 208 (10): 2300–2308.

  • IL-33 expression is increased in the gut of HIV-infected patients.

  • IL-33 is associated with fibrosis and low CD4+ T cell reconstitution.

  • Despite the presence of IL-33, tTreg cells do not produce amphiregulin.

IMMUNE REGULATION

J Immunol (2022) 208 (10): 2309–2318.

  • Berberine induces aerobic glycolysis and expression of GLUT1/HK2 in BMDMs.

  • Berberine priming increases cytokine secretion by BMDMs triggered with LPS.

  • Berberine alleviates Salmonella typhimurium enteritis and endotoxic shock.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2022) 208 (10): 2319–2330.

  • AHR modulates Tfh cell responses during infection in a CD4+ T cell–intrinsic manner.

  • AHR alters the Tfr/Tfh cell ratio and levels of BCL6 and FOXP3 in CD4+ T cells.

  • AHR requires a functional DBD to modulate Tfh and Tfr cells during IAV infection.

J Immunol (2022) 208 (10): 2331–2342.

  • CysLT receptors are expressed at high basal levels within the cornea.

  • CysLT1 and CysLT2 expressed in the cornea are not solely proinflammatory in nature.

  • CysLT receptors may play homeostatic and proresolving roles in the cornea.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2022) 208 (10): 2343–2362.

  • Polymeric EsIgLectin generates higher antibacterial activities than monomer.

  • EsIg bound to EspIgR-Ig1 to promote hemocyte phagocytosis.

  • Hemocyte-derived EsIgLectin entered the intestine at the later phase of inflammation.

J Immunol (2022) 208 (10): 2363–2375.

  • High CO2 (hypercapnia) reduces macrophage activation and migration.

  • Our data implicate a novel CA2/[pH]i axis in CO2 sensing in cells.

  • Patients with lung disease are at risk of developing surgical complications.

J Immunol (2022) 208 (10): 2376–2389.

  • HuR-HNS3 interrupts PARylation of HuR and HuR dimerization.

  • TAT-HuR-HNS3 blocks HuR cytoplasmic distribution and association with target mRNAs.

  • TAT-HuR-HNS3 lowers proinflammatory mediators’ mRNA production.

MUCOSAL IMMUNOLOGY

J Immunol (2022) 208 (10): 2390–2402.

  • ATP and histamine suppress virus-mediated IFN release from airway epithelial cells.

  • Inhibition of IFN release by ATP/histamine occurs through Gq–PKC signaling.

  • P2Y2 and H1 receptor blockade reverses ATP/histamine inhibition of IFN release.

SYSTEMS IMMUNOLOGY

J Immunol (2022) 208 (10): 2403–2424.

  • Lupus susceptibility loci lead to emergence of novel myeloid subpopulations.

  • Myeloid cells from lupus mice have decreased metabolism and Ag presentation.

  • Algorithmic specificity prediction distinguishes TCRs from autoimmune mice.

TUMOR IMMUNOLOGY

J Immunol (2022) 208 (10): 2425–2435.

  • CXCL13 contributes to tumor metastasis by recruiting regulatory B cells.

  • Recruited regulatory B cells affect both innate and adaptive immunity.

  • Lack of CXCL13 increases the efficacy of chemotherapy and PD-1 blockade.

NOVEL IMMUNOLOGICAL METHODS

J Immunol (2022) 208 (10): 2436–2442.

  • We describe a highly effective and accessible approach for the purification of human serum IgE.

  • This method is useful for experimental models in the field of allergy and clinical immunology.

  • It is possible that this method can be scaled up to larger volumes if needed.

Close Modal

or Create an Account

Close Modal
Close Modal